Rocket Pharmaceuticals (RCKT) Financials

$3.86

$0.07 (1.85%)

As on 04-Sep-2026 17:42EDT

Market cap

$424 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	2.15	11.03	9.38	7.10	6.27	5.37
Gross Profit	-2.15	-11.03	-9.38	-7.10	-6.27	-5.37
Operating Expenses	189.50	217.49	273.21	259.66	224.34	167.25
Operating Profit (EBIT)	-191.64	-228.52	-273.21	-259.66	-224.34	-167.25
Other Income	--	--	--	--	--	0.16
Profit before Tax	-8.63	-223.12	-258.75	-245.60	-221.86	-169.07
Provision for Tax	8.62	--	0.00	-245.60	-2.48	0.52
Profit after Tax (Net Income)	-17.25	-223.12	-258.75	-245.60	-221.86	-169.07
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-221.86	-169.07

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	368.83	277.22	463.23	492.57	489.69	454.72
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	22.95	23.02	23.78	25.26	22.95	20.13
Current Liabilities	31.32	30.21	40.68	48.51	39.17	22.17
Total Liabilities	454.42	330.45	527.70	566.34	551.81	497.02

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	133.55	137.72	149.52	188.12	187.75	104.96
Current Assets	289.55	192.73	378.18	378.22	364.06	392.06
Total Assets	712.65	330.45	527.70	566.34	551.81	497.02
Total Debt*	24.80	24.88	25.50	25.04	22.87	22.60
Net Current Assets	--	162.53	337.50	329.72	324.89	369.89

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-190.01	-209.72	-194.92	-178.14	-121.16
Cash Flow from Investing Activities	--	103.77	131.71	-98.07	-69.33	18.85
Cash from Financing Activities	--	0.15	185.74	208.40	155.29	37.68
Net Cash Inflow / Outflow	--	--	--	--	--	-64.63

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.18	-2.01	-2.65	-2.92	-3.04	-2.62
Cash EPS ($)	--	-1.91	-2.56	-2.84	-2.96	-2.54
Adjusted Book Value ($)	--	2.49	4.75	5.86	6.72	7.05
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.71	-2.15	-2.32	-2.44	-1.88
Free Cash Flow per Share ($)	--	-1.71	-2.21	-2.52	-2.56	-2.00

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-56.43	-51.42	-47.68	-44.83	-32.43
ROE (%)	-5.34	-60.27	-54.14	-50.01	-46.98	-35.29
ROA (%)	-2.93	-52.00	-47.30	-43.93	-42.31	-31.08
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	-108,377.56
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	98.47	13.87	-5.39	-10.80	-34.79	-22.94
Net Profit Growth (%)	93.30	13.77	-5.35	-10.70	-31.23	-15.27
EPS Growth (%)	92.72	0.24	0.09	0.04	-0.16	0.01
Book Value Growth (%)	0.95	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.75	-4.74	-10.25	-6.43	-8.32
Price / Book Value	1.13	1.41	2.65	5.11	2.91	3.10
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	52.91	-1.08	-3.55	-9.17	-5.11	-6.60
Close Price ($)	3.42	3.51	12.57	29.97	19.57	21.83
High Price ($)	5.45	13.35	31.47	32.45	24.18	67.48
Low Price ($)	2.40	2.19	11.15	14.89	7.57	20.92
Market Cap ($ Cr)	423.73	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.09	0.06	0.05	0.05	0.05
Short term debt to equity ratio	0.01	0.01	0.01	0.01	0.01	0.01
Current Ratio	9.24	6.38	9.30	7.80	9.29	17.69
Quick Ratio	9.24	--	--	--	--	--
Interest Coverage	-0.83	-116.99	-136.19	-129.98	-115.22	-27.71

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	53.84	31.69	943.27	1,068.48	0.04
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.